ADVERTISEMENT

'Kinaiinggitan': PH the envy of other poor nations in terms of vaccination rate, Roque claims

Published Oct 4, 2021 11:38 am

Presidential Spokesperson Harry Roque claimed on Monday, October 4 that the Philippines is the "envy" of other poor countries when it comes to its vaccination rate against the dreaded coronavirus disease (COVID-19).

THEY'RE ENVIOUS--Presidential Spokesperson Harry Roque hammers home his point during the Resbakuna event on Monday, Oct. 4, 2021. (Screenshot from Facebook live)

Roque, who spoke at the "Resbakuna" event at SM City Clark in Pampanga, made a big deal out of the Philippines' full vaccination of 28 percent out of its eligible population.

"Kaya nga po kapag binabato tayo ng kalaban na palpak tayo, hindi ba nila alam na ang ibang mahihirap ding bansa eh nasa 2 percent pa lang ng mga bakuna, samantalang ang mga mayayamang bansa naguusap na tungkol sa kanilang mga booster shot? (Whenever our critics say that we have failed, don't they know that the vaccination rate of other poo countries is just 2 percent, while the rich countries are already talking about booster shots?)" he said.

"Hindi ba ho yan isang napakalaking accomplishment na samantalang ang mga katulad nating mga bansa na 2 percent pa lamang, nasa 28 percent na tayo dito sa ating bayan (Isn't that a huge accomplishment that while similar countries are at two percent, we've already reached 28 percent here in our country)," noted Roque.

The 28 percent equates to roughly 21 million Filipinos. Metro Manila, the country's economic center, has 75 percent of its population fully vaccinated.

A fully vaccinated person from COVID-19 has had up to two vaccine shots. Subsequent shots are called booster shots.

Roque asked Filipinos to not be fooled by administration critics.

"Hindi po makatarungan ang nangyari pagdating sa distribusyon ng mga bakuna, at ang nagawa po natin dito sa liderato ni President Rodrigo Duterte ay kinaiinggitan ng ibat ibang mga bansa na hindi rin nakabahagi dun sa 85 porsyento ng bakuna (There was injustice in the distribution of vaccines, and what we did under the leadership of President Rodrigo Duterte is now the envy of other countries that were also not given 85 percent of the vaccines)."

President Duterte had earlier assailed wealthier nations for discussing the use of booster shots when there are a lot of people in the world who doesn't have access to even a single shot of the life-saving jabs.

"Ipagdiwang natin ang ating nagawa dahil hindi po gaya ng mga ibang bansa na pinagkaitan ng bakuna, 28 percent national vaccinated na po tayo, 75 percent sa Metro Manila (Let's celebrate our accomplishment because unlike other countries that have been denied access to vaccines, we've achieved a national vaccination rate of 28 percent, with 75 percent in Metro Manila)," Roque said.

Related Tags

resbakuna President Duterte Harry Roque rich countries covid-19 envy vaccination rate 28 percent envious 100421 poor countries fully vaccinated
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.